Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ERα-mediated signaling pathway
Jing Yi, Tianhui Hu, Jun Yuan, Zhikun Liu, Mingtao Tao, Mingyu Ou, Xinru Cheng, Wei Cheng, Yuanyuan Yi, Qingping Xiong
Topics & Concepts
PCSK9EndocrinologyHepatocyteInternal medicineEstrogen receptorBiologyResveratrolLDL receptorCancer researchChemistryCholesterolLipoproteinPharmacologyMedicineIn vitroBiochemistryBreast cancerCancerCholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular DiseasesAntioxidant Activity and Oxidative Stress